R
Rhino Biotech Ltd. Stock Analysis RBRXF
Rhino Biotech Limited is focused on agricultural technology (agritech), biotechnology (biotech), biopharmaceutical (biopharma). The company employs 1 full-time employees The firm's divisions include Fortify RX, AGRITECH RHINO and BioOrganics. Its Fortify RX division produces, manufactures, and distributes cannabis-derived cannabinoids and other natural compounds for use in nutraceuticals and pharmaceuticals as well as health and wellness products. Its AGRITECH RHINO division is engaged in improving plant and fungus genetics through cloning and hybridization technology. Its BioOrganics division is engaged in research and development; preventing contamination and deterioration and extending the lifespan and efficacy of organic compounds.
Read More Rhino Biotech Ltd (RBRXF) Chart
Key Statistics of Rhino Biotech Ltd (RBRXF)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
-P/E Ratio (TTM)
-Market Cap
144.25KAvg. Volume
-Dividend Yield
-Financial Metrics & Statements of Rhino Biotech Ltd (RBRXF)
FAQ's for Rhino Biotech Ltd (RBRXF)
- According to Musaffa’s Shariah screening methodology, Rhino Biotech Ltd (RBRXF) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.